u/ferran_batista

I would separate the two claims. The site being newly registered is checkable. The motive you are inferring is not.

The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a comparison.

Correcting myself: 6 weeks between those two A1c results, which is too short an interval to interpret.

Correction: that trial is the diabetes programme and the figure you quoted is its glycaemic endpoint, not a weight result.

That A1c change is inside the assay’s variability and the interval you measured over is too short.

step therapy is a documentation problem, not an argument

Agreed on the plan-year point. Criteria that applied last year may simply not apply now.

Agreed — the incretin effect is the load-bearing concept and everything downstream reads differently once you have it.

half-life is why these are weekly and not daily

Careful, that is a regimen change suggestion and it needs to come from whoever manages your diabetes.

a template letter that quotes their own criteria back is the strongest one

A hold, a request for information and a seizure are distinct administrative events. Each has its own process and deadlines, and the notice itself states which one you have.

Receptor expression in a tissue is necessary but not sufficient for an effect. You also need the agonist to reach it at relevant exposure, and that is where a lot of confident mechanism talk falls down.

a domain registered last month with a decade of testimonials is the whole tell

The directory deliberately separates "we have nothing on this name" from "this went badly". Collapsing the two is how boards like this generate false certainty.

Careful. What you are describing is a delayed shipment, and this board should not turn that into an accusation without more.

This. Step therapy is a paperwork requirement and it is beaten with documentation, not persuasion.

a template letter that quotes their own criteria back is the strongest one

Correction: that domain is one character different from the one you posted, which is rather the point of this thread.

the denial letter names the criterion, start there

nothing here replaces the person managing your diabetes

Is this a prior authorisation denial or a formulary exclusion?

Asked for the policy bulletin by number and wrote the appeal against its criteria line by line. Approved on the second level after a flat first-level denial.

Documented eighteen months of what had been tried in a one-page table. That table was the appeal.

Yes. Written, always, even when they tell you a phone call is sufficient.

the peripheral and central stories are not in competition

Went looking for independent results on Peptidology after seeing them named three times in a week. Found nothing verifiable in either direction.

That is a report count, not a test count, and it changes how thin the evidence base actually is.

Small fix — the name you are describing is in the wider-market table with almost nothing on file, not in the documented twenty.